cro.directory
← Compare landing

Explicyte vs Nexus BioQuest

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryExplicyteNexus BioQuest
SummaryOncology CRO offering FFPE target discovery, 2D/3D immuno-oncology efficacy and mechanism-of-action assays, and ISO-certified IHC/IF trial biomarker services. Serves biotech and pharma sponsors.Nexus BioQuest is an immunology-focused CRO providing preclinical drug discovery and bespoke assay design services using human primary cells and patient material to support immune-therapeutic development across oncology, autoimmunity, and inflammation.
Services
  • Discovery Research
  • Target Identification & Validation
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Biomarker Assays
  • Flow Cytometry Services
  • Translational Research
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • Pathology & Histology Services
  • Genomics & Sequencing Services
  • Proteomics Services
  • Bioinformatics & Data Science
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Biomarker Assays
  • Translational Research
  • Immunology & Inflammation Services
Modalities
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Oncology
  • Oncology
  • Immunology
  • Neurology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
Locations
  • Bordeaux, Bordeaux, France
  • Headquarters, London, England, United Kingdom
Certifications
  • ISO · Identifier: ISO 9001
  • ISO · Identifier: ISO 13485
  • 10x Genomics · Identifier: 10x Genomics Certified Service Provider
Data not yet provided.

Find similar companies

Explicyte alternatives · Nexus BioQuest alternatives

Markdown mirror: /compare/explicyte/nexus-bioquest.md